Correlation Between ZyVersa Therapeutics and Xenetic Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Xenetic Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Xenetic Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Xenetic Biosciences, you can compare the effects of market volatilities on ZyVersa Therapeutics and Xenetic Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Xenetic Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Xenetic Biosciences.

Diversification Opportunities for ZyVersa Therapeutics and Xenetic Biosciences

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between ZyVersa and Xenetic is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Xenetic Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xenetic Biosciences and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Xenetic Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xenetic Biosciences has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Xenetic Biosciences go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Xenetic Biosciences

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Xenetic Biosciences. In addition to that, ZyVersa Therapeutics is 2.19 times more volatile than Xenetic Biosciences. It trades about -0.15 of its total potential returns per unit of risk. Xenetic Biosciences is currently generating about 0.11 per unit of volatility. If you would invest  360.00  in Xenetic Biosciences on August 24, 2024 and sell it today you would earn a total of  41.00  from holding Xenetic Biosciences or generate 11.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  Xenetic Biosciences

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Xenetic Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Xenetic Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy forward indicators, Xenetic Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

ZyVersa Therapeutics and Xenetic Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and Xenetic Biosciences

The main advantage of trading using opposite ZyVersa Therapeutics and Xenetic Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Xenetic Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xenetic Biosciences will offset losses from the drop in Xenetic Biosciences' long position.
The idea behind ZyVersa Therapeutics and Xenetic Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios